409406007: Bevacizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Angiogenesis inhibitor\Bevacizumab (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Bevacizumab (substance)

\Drug or medicament (substance)\Antineoplastic agent (substance)\Bevacizumab (substance)
\Drug or medicament (substance)\Monoclonal antibody\Bevacizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Bevacizumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2464857019 Bevacizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2471192013 Bevacizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
70971000195115 Bevacizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
34891000188111 Bévacizumab fr Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193131000077112 bevacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
794791000172111 bévacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
55881000195117 bevacizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bevacizumab (substance)	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Bevacizumab (substance)	Is a	Angiogenesis inhibitor	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Bevacizumab (substance)	Has disposition (attribute)	Angiogenesis inhibitor (disposition)	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Bevacizumab (substance)	Has disposition (attribute)	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing bevacizumab (medicinal product)	Has active ingredient	True	Bevacizumab (substance)	Inferred relationship	Some	1
Bevacizumab 25mg/mL injection solution 4mL vial	Has active ingredient	False	Bevacizumab (substance)	Inferred relationship	Some
Bevacizumab 25mg/mL injection solution 16mL vial	Has active ingredient	False	Bevacizumab (substance)	Inferred relationship	Some
Product containing bevacizumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial	Has basis of strength substance (attribute)	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial	Has precise active ingredient	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial	Has basis of strength substance (attribute)	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial	Has precise active ingredient	False	Bevacizumab (substance)	Inferred relationship	Some	1
Bevacizumab only product	Has active ingredient	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing only bevacizumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Bevacizumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets